Paper60622
Oral zinc sulphate in rheumatoid arthritis.
Simkin PA. Lancet, 1976. Cited by 155 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Oral zinc sulphate in rheumatoid arthritis. Papers, record 60622. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/60622
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Zinc | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Follow-Up Studies | |
| Humans | |
| Joints | |
| Middle Aged | |
| Placebos | |
| Time Factors |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,737,786 | The Role of Metals and Trace Elements in the Pathogenesis of Osteoarthritis and Other Rheumatic Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737786 | PubMed |
| 41,609,972 | Exploring the nexus between inflammation and mobility through the lens of healthy aging: current scenario and future perspectives. | Aging Clin Exp Res | 2026 | https://conductscience.org/library/papers/41609972 | PubMed |
| 41,122,192 | Zinc, Copper, and Manganese Supplementations in Rheumatic Disease: A Narrative Review. | Mediterr J Rheumatol | 2025 | https://conductscience.org/library/papers/41122192 | PubMed |
| 40,806,618 | Trace Elements-Role in Joint Function and Impact on Joint Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806618 | PubMed |
| 40,557,185 | Dietary Recommendations from the Moroccan Society for Rheumatology (SMR) for Patients with Chronic Inflammatory Rheumatic Diseases. | Mediterr J Rheumatol | 2025 | https://conductscience.org/library/papers/40557185 | PubMed |
| 39,535,573 | Therapeutic Dose of Zinc Aspartate and Zinc Citrate Attenuates Disease Activity Indices in Rheumatoid Arthritis. | Biol Trace Elem Res | 2025 | https://conductscience.org/library/papers/39535573 | PubMed |
| 38,003,398 | Carnosine, Zinc and Copper: A Menage a Trois in Bone and Cartilage Protection. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003398 | PubMed |
| 35,654,458 | Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. | RMD Open | 2022 | https://conductscience.org/library/papers/35654458 | PubMed |
| 35,190,326 | Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection. | J Trace Elem Med Biol | 2022 | https://conductscience.org/library/papers/35190326 | PubMed |
| 34,744,184 | Synthesis, crystal structure, potential drug properties for Coronavirus of Co(II) and Zn(II) 2-chlorobenzoate with 3-cyanopyridine complexes. | J Mol Struct | 2022 | https://conductscience.org/library/papers/34744184 | PubMed |
| 34,631,438 | Embracing cancer immunotherapy with vital micronutrients. | World J Clin Oncol | 2021 | https://conductscience.org/library/papers/34631438 | PubMed |
| 29,142,320 | Biocompatibility and biodegradation studies of a commercial zinc alloy for temporary mini-implant applications. | Sci Rep | 2017 | https://conductscience.org/library/papers/29142320 | PubMed |
| 27,378,206 | Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis. | Br J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/27378206 | PubMed |
| 25,888,289 | The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta-analysis. | BMC Fam Pract | 2015 | https://conductscience.org/library/papers/25888289 | PubMed |
| 21,769,305 | Zinc lozenges may shorten the duration of colds: a systematic review. | Open Respir Med J | 2011 | https://conductscience.org/library/papers/21769305 | PubMed |
| 17,622,302 | Differential gene expression after zinc supplementation and deprivation in human leukocyte subsets. | Mol Med | 2007 | https://conductscience.org/library/papers/17622302 | PubMed |
| 9,805,181 | Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1 beta and tumour necrosis factor alpha. | Clin Rheumatol | 1998 | https://conductscience.org/library/papers/9805181 | PubMed |
| 9,694,055 | Induction of drug resistance to gold sodium thiomalate in a monocyte cell line, THP-1. | Clin Rheumatol | 1998 | https://conductscience.org/library/papers/9694055 | PubMed |
| 9,561,927 | Neutrophil behavior following exposure to in vivo or in vitro zinc in normal and acutely-inflamed rats: studies on lysozyme secretion, superoxide anion release and platelet adhesion. | Inflammation | 1998 | https://conductscience.org/library/papers/9561927 | PubMed |
| 8,304,248 | Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies. | Agents Actions | 1993 | https://conductscience.org/library/papers/8304248 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/60622
GET https://conductscience.org/api/papers/v1/60622/cited_by?page=2